StockData
Biomerica Inc logo

Biomerica Inc (BMRA) stock

BMRANasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 15, 2026Score 8/3049% below fair value
$1.09−0.15 (-11.74%)

Close on Nov 18, 2026Market cap $5.01MP/E –Yield –

Biomerica pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Biomerica's pe ratio was 124.8× on Dec 31, 2013, against 7.8× a year earlier. Over the last 3 years it ranged from 7.4× to 150.4×, with a median of 11.0×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2013Dec 31, 2013124.8×+117.0
2012Dec 31, 20127.8×−3.2
2011Dec 30, 201111.0×–

More Biomerica figures

See a number that looks wrong?